Mitchell Sinkler & Starr PA Purchases 100 Shares of Zoetis Inc. $ZTS

Mitchell Sinkler & Starr PA lifted its position in Zoetis Inc. (NYSE:ZTS) by 5.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,005 shares of the company’s stock after buying an additional 100 shares during the period. Mitchell Sinkler & Starr PA’s holdings in Zoetis were worth $313,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ZTS. Brighton Jones LLC lifted its stake in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after buying an additional 2,978 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in shares of Zoetis by 11.1% in the first quarter. Farther Finance Advisors LLC now owns 4,738 shares of the company’s stock worth $767,000 after buying an additional 474 shares in the last quarter. SG Americas Securities LLC lifted its stake in shares of Zoetis by 61.8% in the first quarter. SG Americas Securities LLC now owns 20,782 shares of the company’s stock worth $3,422,000 after buying an additional 7,940 shares in the last quarter. Rockland Trust Co. lifted its stake in shares of Zoetis by 1.3% in the first quarter. Rockland Trust Co. now owns 6,379 shares of the company’s stock worth $1,050,000 after buying an additional 83 shares in the last quarter. Finally, NorthCrest Asset Manangement LLC lifted its stake in shares of Zoetis by 5.8% in the first quarter. NorthCrest Asset Manangement LLC now owns 26,389 shares of the company’s stock worth $4,345,000 after buying an additional 1,443 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ZTS. Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday. Piper Sandler boosted their price objective on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a report on Monday, August 11th. Argus reissued a “buy” rating and set a $190.00 price objective on shares of Zoetis in a report on Tuesday, September 9th. Stifel Nicolaus cut shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price objective for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Finally, Leerink Partnrs cut shares of Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Zoetis presently has an average rating of “Hold” and an average price target of $196.71.

Zoetis Stock Down 1.6%

Shares of ZTS stock opened at $141.05 on Friday. Zoetis Inc. has a 12 month low of $139.34 and a 12 month high of $196.55. The stock has a market cap of $62.51 billion, a P/E ratio of 24.28, a P/E/G ratio of 2.26 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The company has a 50 day simple moving average of $149.24 and a two-hundred day simple moving average of $154.41.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the company earned $1.56 earnings per share. The firm’s revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s dividend payout ratio is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.